Non-vitamin K vs vitamin K oral anticoagulants in patients aged > 80 year with atrial fibrillation and low body weight.
Vincenzo RussoEmilio AttenaMarco Di MaioAndreina CarboneValentina ParisiAnna RagoFabrizio Vincenzo GriecoAgostino BuonauroPaolo GolinoGerardo NigroPublished in: European journal of clinical investigation (2020)
Our real-world data might suggest the safe and efficacy use of NOACs in this setting of population, justified by a reduction in overall mortality over VKAs. Further studies are needed to confirm these data.
Keyphrases
- oral anticoagulants
- atrial fibrillation
- body weight
- end stage renal disease
- electronic health record
- chronic kidney disease
- newly diagnosed
- ejection fraction
- big data
- catheter ablation
- left atrial
- heart failure
- prognostic factors
- left atrial appendage
- percutaneous coronary intervention
- cardiovascular events
- direct oral anticoagulants
- cardiovascular disease
- acute coronary syndrome